UVA-developed artificial pancreas benefits both kids and adults with diabetes, new analysis finds
An artificial pancreas developed at the University of Virginia Center for Diabetes Technology improves blood sugar control for people ages 2 to 72 with type 1 diabetes, according to a new combined analysis of three clinical trials.
Across the three trials, participants using the artificial pancreas spent an average of 2.8 more hours per dayin their target blood sugar range compared with participants in control groups who used standard methods for managing their blood sugar.
Manufactured by Tandem Diabetes Care and sold as the Control-IQ system, the artificial pancreas is ...








